Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.43 +0.08 (+0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Income towards Parent Company (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) posted Income towards Parent Company of $30.35 million for Q2 2026, down 2.2% from $31.03 million a year earlier but up 372.7% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Income towards Parent Company (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Amphastar Pharmaceuticals was $78.55 million, down 41.7% year-over-year; for FY2025, it came in at $98.09 million, down 38.5% from FY2024.

  • Annual Income towards Parent Company shows a five-year compound annual growth rate of 133.8% (FY2020 to FY2025).
  • In prior years, Amphastar Pharmaceuticals' Income towards Parent Company was $159.52 million in FY2024 (+16.0%), $137.55 million in FY2023 (+50.5%), $91.39 million in FY2022 (+47.1%) and $62.12 million in FY2021.
  • Quarterly Income towards Parent Company has run from a low of $6.42 million in Q1 2026 to a high of $49.22 million in Q3 2023 over five years.
  • On a year-over-year basis, Income towards Parent Company has declined in each of the last six quarters, with an average decline of 30.3% over the last eight quarters.
  • The strongest year-over-year quarter for Income towards Parent Company in the past five years was Q3 2021, with growth of 654.0%; the weakest was Q1 2026, with a decline of 74.6%.
  • According to Business Quant data, Income towards Parent Company for the three prior quarters was $6.42 million (Q1 2026), $24.43 million (Q4 2025) and $17.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Amphastar Pharmaceuticals 1.08 Bn -59.50 Mn 93.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.35 Mn
Mar 31, 2026 6.42 Mn
Dec 31, 2025 24.43 Mn
Sep 30, 2025 17.35 Mn
Jun 30, 2025 31.03 Mn
Mar 31, 2025 25.29 Mn
Dec 31, 2024 37.96 Mn
Sep 30, 2024 40.43 Mn
Jun 30, 2024 37.95 Mn
Mar 31, 2024 43.18 Mn
Dec 31, 2023 36.17 Mn
Sep 30, 2023 49.22 Mn
Jun 30, 2023 26.12 Mn
Mar 31, 2023 26.03 Mn
Dec 31, 2022 33.91 Mn
Sep 30, 2022 15.87 Mn
Jun 30, 2022 17.35 Mn
Mar 31, 2022 24.25 Mn
Dec 31, 2021 19.76 Mn
Sep 30, 2021 29.55 Mn
API Access

Amphastar Pharmaceuticals Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=AMPH&period=max&api_key=YOUR_API_KEY